Medizinische Universität Graz - Research portal

Navigation/Search

• Researchers.
  • Curriculum.
  • Publications.
  • Presentations.
• Institutions.
• Projects.
• Publications.
• Partners.
• Sponsors.
• Equipment.
• Knowhow.
• Fields of Research.

Skofler Christina |

** = Publications listed in SCI/SSCI/Pubmed

2024

Full paper/article (Journal)

** Bonstingl, L; Skofler, C; Ulz, C; Zinnegger, M; Sallinger, K; Schönberger, J; Schuch, K; Pankratz, K; Borrás-Cherrier, A; Somodi, V; Abuja, PM; Oberauner-Wappis, L; Moser, T; Heitzer, E; Bauernhofer, T; Kroneis, T; El-Heliebi, A Clinical Application of ISO and CEN/TS Standards for Liquid Biopsies-Information Everybody Wants but Nobody Wants to Pay For.
Clin Chem. 2024; 70(9): 1140-1150. Doi: 10.1093/clinchem/hvae079
Web of Science PubMed FullText FullText_MUG

 

** Bonstingl, L; Zinnegger, M; Sallinger, K; Pankratz, K; Müller, CT; Pritz, E; Odar, C; Skofler, C; Ulz, C; Oberauner-Wappis, L; Borrás-Cherrier, A; Somođi, V; Heitzer, E; Kroneis, T; Bauernhofer, T; El-Heliebi, A Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: Unveiling resistance mechanisms with the CoDuCo in situ assay.
Biomark Res. 2024; 12(1): 140 Doi: 10.1186/s40364-024-00680-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Correction

** Bonstingl, L; Zinnegger, M; Sallinger, K; Pankratz, K; Müller, CT; Pritz, E; Odar, C; Skofler, C; Ulz, C; Oberauner-Wappis, L; Borrás-Cherrier, A; Somođi, V; Heitzer, E; Kroneis, T; Bauernhofer, T; El-Heliebi, A Correction: Advanced single-cell and spatial analysis with high-multiplex characterization of circulating tumor cells and tumor tissue in prostate cancer: unveiling resistance mechanisms with the CoDuCo in situ assay.
Biomark Res. 2024; 12(1): 150 Doi: 10.1186/s40364-024-00698-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2023

Full paper/article (Journal)

** Alcaniz, J; Winkler, L; Dahlmann, M; Becker, M; Orthmann, A; Haybaeck, J; Krassnig, S; Skofler, C; Kratzsch, T; Kuhn, SA; Jödicke, A; Linnebacher, M; Fichtner, I; Walther, W; Hoffmann, J Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.
Front Oncol. 2023; 13:1129627 Doi: 10.3389/fonc.2023.1129627 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kendzia, S; Franke, S; Kröhler, T; Golob-Schwarzl, N; Schweiger, C; Toeglhofer, AM; Skofler, C; Uranitsch, S; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Yaspo, ML; Reinhard, C; Schäfer, R; Keilholz, U; Regenbrecht, C; Schicho, R; Fickert, P; Lax, SF; Erdmann, F; Schulz, MH; Kiemer, AK; Haybaeck, J; Kessler, SM A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
Mol Cancer. 2023; 22(1):89 Doi: 10.1186/s12943-023-01787-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Krassnig, S; Leber, SL; Orthmann, A; Golob-Schwarzl, N; Huber, HJ; Wohlrab, C; Skofler, C; Pennauer, M; Raicht, A; Birkl-Toeglhofer, AM; Naumann, M; Mahdy-Ali, K; von, Campe, G; Leoni, M; Alcaniz, J; Hoffmann, J; Wälchli, T; Weis, S; Benesch, M; Haybaeck, J Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
J Neurooncol. 2023; 165(1):91-100 Doi: 10.1007/s11060-023-04451-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2022

Abstract (Journal)

** Alcaniz, J; Dahlmann, M; Conrad, T; Orthmann, A; Haybaeck, J; Krassnig, S; Wodlej, C; Birkl-Toeglhofer, AM; Kratzsch, T; Kuhn, SA; Joedicke, A; Iduna, F; Hoffmann, J; Walther, W Molecular analyses of Glioblastoma patient-derived xenograft (PDX) models identify potential targets in treatment resistant tumors
ONCOL RES TREAT. Abstracts 35. Deutscher Krebskongress. 2022; 45(SUPPL 3):47-47.-35. Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung; NOV 13-16, 2022; Berlin, GERMANY. [Poster]
Web of Science

 

** El-Heliebi, A; Prietl, B; Mahdy-Ali, K; Purkart, TU; Gerlitz, L; Skofler, C; Stanzer, S; Franz, J; Harbusch, N; Madl, T; Widhalm, G; Rossler, K; Tomberger, M; Mattersdorfer, K; Kroneis, T; Oberhuber, M; Pieber, TR Next generation drug screening platform: generation of patient-derived cells for ex vivo drug response studies of gliomas
NEURO-ONCOLOGY. 2022; 24: -Brain Tumor Meeting 2022; May 19-20, 2022; Berlin, GERMANY. Doi: 10.1093/neuonc/noac174.180 [Poster]
Web of Science FullText FullText_MUG

 

** El-Heliebi, A; Urbanic-Purkart, T; Mahdy-Ali, K; Skofler, C; Gerlitz, L; Stanzer, S; Franz, J; Harbusch, N; Madl, T; Widhalm, G; Rossler, K; Tomberger, M; Mattersdorfer, K; Kroneis, T; Oberhuber, M; Pieber, T; Prietl, B PATIENT-DERIVED CELLS FOR EX VIVO DRUG SCREENING STUDIES OF GLIOMAS
NEURO-ONCOLOGY. 2022; 24: 209-209.-27th Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO); NOV 16-20, 2022; Tampa, FL. [Poster]
Web of Science

 

2021

Full paper/article (Journal)

** Krassnig, S; Wohlrab, C; Golob-Schwarzl, N; Raicht, A; Schatz, C; Birkl-Toeglhofer, AM; Skofler, C; Gantenbein, N; Leoni, M; Asslaber, M; Leber, SL; Mahdy-Ali, K; von Campe, G; Mayer, M; Borenich, A; Weis, S; Benesch, M; Haybaeck, J A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.
Cancers (Basel). 2021; 13(6): Doi: 10.3390/cancers13061482 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Skofler, C; Kleinegger, F; Krassnig, S; Birkl-Toeglhofer, AM; Singer, G; Till, H; Benesch, M; Cencic, R; Porco, JA; Pelletier, J; Castellani, C; Raicht, A; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma.
Cells. 2021; 10(2): Doi: 10.3390/cells10020301 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Full paper/article (Journal)

** Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Gogg-Kamerer, M; Birkl-Toeglhofer, AM; Petzold, J; Aigelsreiter, A; Thalhammer, M; Park, YN; Haybaeck, J Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
J Cancer Res Clin Oncol. 2019; 145(11): 2699-2711. Doi: 10.1007/s00432-019-03030-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kleinegger, F; Hofer, E; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Stallinger, A; Petzold, J; Orlova, A; Krassnig, S; Reihs, R; Niedrist, T; Mangge, H; Park, YN; Thalhammer, M; Aigelsreiter, A; Lax, S; Garbers, C; Fickert, P; Rose-John, S; Moriggl, R; Rinner, B; Haybaeck, J Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Biochim Biophys Acta Mol Basis Dis. 2019; 1865(2):308-321 Doi: 10.1016/j.bbadis.2018.11.006 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Sele, M; Wernitznig, S; Lipovšek, S; Radulović, S; Haybaeck, J; Birkl-Toeglhofer, AM; Wodlej, C; Kleinegger, F; Sygulla, S; Leoni, M; Ropele, S; Leitinger, G Optimization of ultrastructural preservation of human brain for transmission electron microscopy after long post-mortem intervals.
Acta Neuropathol Commun. 2019; 7(1):144-144 Doi: 10.1186/s40478-019-0794-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wernitznig, S; Reichmann, F; Sele, M; Birkl, C; Haybäck, J; Kleinegger, F; Birkl-Töglhofer, A; Krassnig, S; Wodlej, C; Holzer, P; Kummer, D; Bock, E; Leitinger, G An Unbiased Approach of Sampling TEM Sections in Neuroscience.
J Vis Exp. 2019; (146): Doi: 10.3791/58745 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wodlej, C; Riedl, S; Rinner, B; Leber, R; Drechsler, C; Voelker, DR; Choi, JY; Lohner, K; Zweytick, D Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
PLoS One. 2019; 14(1): e0211187-e0211187. Doi: 10.1371/journal.pone.0211187 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2018

Full paper/article (Journal)

** Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Krassnig, S; Wodlej, C; Brcic, L; Lindenmann, J; Fink-Neuboeck, N; Gollowitsch, F; Stacher-Priehse, E; Asslaber, M; Gogg-Kamerer, M; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Sokolova, O; Naumann, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.
Eur J Cancer. 2018; 101(4):165-180 Doi: 10.1016/j.ejca.2018.07.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Gantenbein, N; Wodlej, C; Smolle, E; Thalhammer, M; Kornprat, P; Lackner, K; Brcic, I; Spindelboeck, W; Kump, P; Lipp, R; Haybaeck, J Are eIFs Ingredients for Neuroendocrine Tumorigenesis?
NEUROENDOCRINOLOGY. 2018; 106: 5-5.-15th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 07-09, 2018; Barcelona, SPAIN. [Poster]
Web of Science

 

** Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Toeglhofer, AM; Krassnig, S; Thalhammer, M; Aigelsreiter, A; Hayback, J Eukaryotic Translation Initiation Factors Might Represent a Potential Therapeutic Target for Gallbladder Cancer
ONCOL RES TREAT. 2018; 41: 68-68.-33. Deutscher Krebs Kongress; FEB 21-24, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

** Riedl, S; Rinner, B; Schaider, H; Liegl-Atzwanger, B; Wodlej, C; Grissenberger, S; Preishuber-Pflugl, J; Lohner, K; Zweytick, D Fighting melanoma - human lactoferricin derived peptides kill cancer cells by inducing severe stress and apoptosis
J PEPT SCI. 2018; 24: S140-S141. [Poster]
Web of Science

 

** Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Hayback, J The Role of Eukaryotic Translation Initiation Factors as Potential Targets in Neuroblastoma
ONCOL RES TREAT. 2018; 41: 131-131.-33. Deutscher Krebs Kongress; FEB, 21-24, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

2017

Full paper/article (Journal)

** Golob-Schwarzl, N; Schweiger, C; Koller, C; Krassnig, S; Gogg-Kamerer, M; Gantenbein, N; Toeglhofer, AM; Wodlej, C; Bergler, H; Pertschy, B; Uranitsch, S; Holter, M; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Regenbrecht, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.
Oncotarget. 2017; 8(60):101224-101243 Doi: 10.18632/oncotarget.20642 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Golob-Schwarzl, N; Krassnig, S; Park, Y; Gogg-Kamerer, M; Wodlej, C; Vierlinger, K; Schroeder, F; Rhee, H; Schicho, R; Fickert, P; Haybaeck, J PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors as new biomarkers in liver cancer
VIRCHOWS ARCH. 2017; 471: S164-S164. [Poster]
Web of Science

 

** Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46. [Oral Communication]
Web of Science

 

** Riedl, S; Rinner, B; Schaider, H; Liegl-Atzwanger, B; Wodlej, C; Lohner, K; Zweytick, D Human lactoferricin derived peptides trigger apoptosis in malignant melanoma in vitro and in vivo
EUR BIOPHYS J BIOPHY. 2017; 46: S390-S390.-19th IUPAB Congress / 11th EBSA Congress; JUL 16-20, 2017; British Biophys Soc, Edinburgh, SCOTLAND. [Poster]
Web of Science

 

** Riedl, S; Rinner, B; Schaider, H; Liegl-Atzwanger, B; Wodlej, C; Lohner, K; Zweytick, D Human Lactoferricin Derived Peptides Induce Apoptosis Specifically in Cancer Cells through Targeting Membranous Phosphatidylserine
BIOPHYS J. 2017; 112(3):185A-185A.-61st Annual Meeting of the Biophysical-Society; FEB 11-15, 2017; New Orleans, LA. Doi: 10.1016/j.bpj.2016.11.1027 [Poster]
Web of Science FullText FullText_MUG

 

** Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J Eukaryotic initiation factors are altered in Alzheimer's disease
VIRCHOWS ARCH. 2017; 471: S218-S219. [Poster]
Web of Science

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint